Frequently Asked Question About Ketamine Infusion Therapy
Please do not consume solid food, orange juice, pulp-filled juices, or non-clear broths or soups in the six hours preceding your appointment. You may have transparent liquids such as water, clear broth, apple juice, white grape juice (not dark), black coffee (NO DAIRY OR CREAMER), or clear tea (no milk or leaves) up to two hours prior to your appointment.
PLEASE REFRAIN FROM CONSUMING ALCOHOL, SMOKING OR INGESTING MARIJUANA, OR USING COCAINE, HEROIN, OR OTHER ILLICIT SUBSTANCES. Not only can they pose a safety risk when combined with ketamine treatment, but also they can interfere with the effectiveness of ketamine therapy.
Ketamine is a Schedule III anesthetic agent. It was first developed in 1962 and later FDA approved for clinical use in 1970 primarily for use during the Vietnam War. Ketamine has had a tainted history because, much like similar medications that can cause dissociative effects, Ketamine became a drug of abuse (Special K). However, Ketamine continued to be a successful anesthetic being used in hospitals, dentist offices and medical practices with an excellent safety record.
In the past 5 – 7 years Ketamine was identified as having beneficial effects on patients with depression, suicidal ideations, anxiety, Bipolar disorder, PTSD and certain neuro-pathic pain syndromes. A large number of very reputable hospitals and organizations have studied Ketamine’s effectiveness in these areas and have shown very promising results.
Ketamine’s anesthetic effects are mediated by interactions with a member of the glutamate receptor family, the NMDA receptor. It interacts with other receptors as well, including opioid receptors, dopamine receptors, and a receptor known as the AMPA receptor, which is thought to be an important component of its antidepressant effects.
Rather than targeting neurotransmitters in the brain, ketamine is thought to target gene expression and protein manufacture in certain important brain pathways or circuits. It appears that ketamine restores brain synapses, both structurally and functionally, that have been damaged by the disease of depression.
Unfortunately, since Ketamine is out of it’s patent period the race is on to replicate Ketamine’s effectiveness into a new, marketable medication.
The treatment is here and available now. There is hope. There is help.